ClinicalTrials.Veeva

Menu

The Effect of Ketamine Infusion on Lumbar Surgery

Yonsei University logo

Yonsei University

Status and phase

Unknown
Phase 4

Conditions

Chronic Low Back Pain

Treatments

Drug: Ketamine

Study type

Interventional

Funder types

Other

Identifiers

NCT02154438
3-2014-0062

Details and patient eligibility

About

The purpose of this study is to evaluate the effect of ketamine infusion for reduction of neuropathic pain and improvement of quality of life after lumbar surgery.

Full description

Neuropathic pain defined as 'pain caused by a lesion or disease of the somatosensory system'. Neuropathic pain is 20 - 35% of low back pain.

Ketamine is categorized as N-methyl D-aspartate receptor antagonist. Ketamine has an analgesic effect in low dose and anesthetic effect in relative high dose. Also, ketamine is used in chronic neuropathic pain as postherpetic neuralgia., phantom pain, central neuropathic pain, complex regional pain syndrome, ischemic pain.

In this study, ketamine will be infused during lumbar surgery in randomized, double-blind and double-blind parallel group control trial.

Enrollment

56 estimated patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Undergoing lumbar spine surgery due to back pain patients
  • American Physical Status Classification I or II

Exclusion criteria

  • less than 3 month of back pain
  • past history of operation at lumbar area
  • past history of glucoma, drug abuse, alcohol abuse
  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

56 participants in 2 patient groups, including a placebo group

ketamine
Experimental group
Description:
ketamine 0.5mg/kg loading dose and followed by 0.5mg/kg/h during operation
Treatment:
Drug: Ketamine
Placebo
Placebo Comparator group
Description:
normal saline 0.5mg/kg loading dose and followed by 0.5mg/kg/h during operation

Trial contacts and locations

1

Loading...

Central trial contact

Cholhee Park, MD; Kyung Hyun Kim, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems